Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency

References

• BatorovaAMartinowitzUContinuous infusion of coagulation factorsHaemophilia20028317017712010406
   PubMed Web of Science ®Google Scholar
• MartinowitzUPSchulmanSContinuous infusion of factor concentrates: review of use in hemophilia A and demonstration of safety and efficacy in hemophilia BActa Haematol199594suppl 135427571993
   PubMed Web of Science ®Google Scholar
• BrinkhousKMHemophiliaBull N Y Acad Med195430532534213150001
   PubMedGoogle Scholar
• BonaRDWeinsteinRAWeismanSJBartolomeoARicklesFRThe use of continuous infusion of factor concentrates in the treatment of hemophiliaAm J Hematol19893218132502914
   PubMed Web of Science ®Google Scholar
• HathawayWEChristianMJClarkeSLHasibaUComparison of continuous and intermittent factor VIII concentrate therapy in hemophilia AAm J Hematol198417185886430068
   PubMed Web of Science ®Google Scholar
• McmillanCWWebsterWPRobertsHRBlytheWBContinuous intravenous infusion of factor VIII in classic haemophiliaBr J Haematol19701866596675428626
   PubMed Web of Science ®Google Scholar
• SchulmanSVaronDKellerNGitelSMartinowitzUMonoclonal purified F VIII for continuous infusion: stability, microbiological safety and clinical experienceThromb Haemost19947234034077855792
   PubMed Web of Science ®Google Scholar
• WeinsteinREBonaRDRicklesFRContinuous infusion of monoclonal antibody-purified factor VIIIAm J Hematol19913632112121899966
   PubMed Web of Science ®Google Scholar
• VaronDMartinowitzUContinuous infusion therapy in haemophiliaHaemophilia1998444314359873771
   PubMed Web of Science ®Google Scholar
• SrivastavaABrewerAKMauser-BunschotenEPGuidelines for the management of hemophiliaHaemophilia2013191e1e4722776238
   PubMed Web of Science ®Google Scholar
• BatorovaAMartinowitzUIntermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgeryBr J Haematol2000110371572010997985
   PubMed Web of Science ®Google Scholar
• BidlingmaierCDemlMMKurnikKContinuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injectionsHaemophilia200612321221716643203
   PubMed Web of Science ®Google Scholar
• MartinowitzULuboshitzJBashariDStability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophiliaHaemophilia200915367668519298381
   PubMed Web of Science ®Google Scholar
• JurlanderBThimLKlausenNKRecombinant activated factor VII (rFVIIa): characterization, manufacturing, and clinical developmentSemin Thromb Hemost200127437338411547359
   PubMed Web of Science ®Google Scholar
• HednerUExperiences with recombinant factor VIIa in haemophiliacsCurr Stud Hematol Blood Transfus1991586368
   Google Scholar
• NovoSeven RT [package insert]Plainsboro, NJNovo Nordisk Inc.2017
   Google Scholar
• SchulmanSSafety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI GroupHaemophilia1998445645679873795
   PubMed Web of Science ®Google Scholar
• ShapiroADGilchristGSHootsWKCooperHAGastineauDAProspective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgeryThromb Haemost19988057737789843170
   PubMed Web of Science ®Google Scholar
• SantagostinoEMorfiniMRocinoABaudoFScaraggiFAGringeriARelationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitorsThromb Haemost200186495495811686352
   PubMed Web of Science ®Google Scholar
• SchulmanSD’OironRMartinowitzUExperiences with continuous infusion of recombinant activated factor VIIBlood Coagul Fibrinolysis19989suppl 1S97S1019819037
   PubMed Web of Science ®Google Scholar
• SchulmanSrFVIIa-CI GroupContinuous infusion of recombinant factor VIIa in hemophilic patients with inhibitors: safety, monitoring, and cost effectivenessSemin Thromb Hemost200026442142411092218
   PubMed Web of Science ®Google Scholar
• SmithMPLudlamCACollinsPWElective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleedingThromb Haemost200186494995311686351
   PubMed Web of Science ®Google Scholar
• PruthiRKMathewPValentinoLAHaemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trialThromb Haemost200798472673217938794
   PubMed Web of Science ®Google Scholar
• TakedaniHShimaMHorikoshiYTen-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in JapanHaemophilia201521337437925521821
   PubMed Web of Science ®Google Scholar
• ChuansumritAIsarangkuraPAngchaisuksiriPControlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: continuous infusion and bolus injectionHaemophilia200062616510781189
   PubMed Web of Science ®Google Scholar
• KenetGLubetskyAGitelSLuboshitzJVaronDMartinowitzUTreatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VIIBlood Coagul Fibrinolysis200011suppl 1S35S3810850562
   PubMed Web of Science ®Google Scholar
• Mauser-BunschotenEPKoopmanMMGoede-BolderADEfficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitorsHaemophilia20028564965612199674
   PubMed Web of Science ®Google Scholar
• LudlamCASmithMPMorfiniMGringeriASantagostinoESavidgeGFA prospective study of recombinant activated factor VII administered by continuous infusion to inhibitor patients undergoing elective major orthopaedic surgery: a pharmacokinetic and efficacy evaluationBr J Haematol2003120580881312614214
   PubMed Web of Science ®Google Scholar
• KenetGLubetskyALuboshitzJMartinowitzUA new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven)J Thromb Haemost20031345045512871449
   PubMed Web of Science ®Google Scholar
• TakedaniHKawaharaHKajiwaraMMajor orthopaedic surgeries for haemophilia with inhibitors using rFVIIaHaemophilia201016229029519925628
   PubMed Web of Science ®Google Scholar
• OguraTHorikoshiYKakazuMRecombinant factor VII (rFVIIa) by continuous infusion for pediatric haemophilia patients with inhibitorsJ Thromb Haemost20119suppl 2968
   Google Scholar
• EttingshausenCEAuerswaldGAubergerKSaguerIMKreuzWEfficacy and safety of continuous infusion of recombinant factor VIIa in pediatric hemophilia A patients with high titer inhibitorsBlood1999941052
   Web of Science ®Google Scholar
• HabermannBHochmuthKHovyLScharrerIKurthAHManagement of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven): a single centre experienceHaemophilia200410670571215569165
   PubMed Web of Science ®Google Scholar
• SolimenoLPPerfettoOSPastaGSantagostinoETotal joint replacement in patients with inhibitorsHaemophilia200612suppl 311311616684005
   PubMed Web of Science ®Google Scholar
• JenkinsPJEkrolILawsonGMTotal knee replacement in patients with haemophilia: the Scottish experienceScott Med J201358422322724215041
   PubMed Web of Science ®Google Scholar
• BatorovaAPrigancovaTJankovicovaDManagement of iliopsoas hematomas in patients with hemophiliaPoster presented at: 7th Annual Congress of the European Association for Haemophilia and Allied Disorders2014Brussels, Belgium
   Google Scholar
• MancusoMEPastaGFasuloMRPeyvandiFSolimenoLPSantagostinoEElective orthopedic surgery in patients with hemophilia and inhibitors: still a big challenge for haematologists?Poster P-T-051 presented at: 31st International Congress of the World Federation of Hemophilia2014Melbourne, Australia
   Google Scholar
• LinariSCarulliCMartiniCShort and long-term outcomes in hemophilia patients with inhibitors undergoing orthopedic prosthetic surgeryPoster C046 presented at: 45th National Congress of the Italian Society of Hematology2015Florence, Italy
   Google Scholar
• GringeriASantagostinoEMannucciPMFailure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibodyHaemostasis199121114
   Google Scholar
• SchulmanSBech JensenMVaronDFeasibility of using recombinant factor VIIa in continuous infusionThromb Haemost19967534324368701403
   PubMed Web of Science ®Google Scholar
• StieltjesNOunnougheneNVassilieffDSultanYFailure of recombinant factor VIIa to control surgical bleeding in a severe hemophilia A patient with inhibitor and possible DICPoster PS-202 presented at: 15th Congress of the International Society on Thrombosis and Haemostasis1997Florence, Italy
   Google Scholar
• VermylenJPeerlinckKOptimal care of inhibitor patients during surgeryEur J Haematol Suppl19986315179882927
   PubMedGoogle Scholar
• MénartCCognetVPetitPYMassignonDNégrierCManagement of an anti-factor VIII inhibitor occurring during surgical procedure with continuous infusion of NovosevenBlood Coagul Fibrinolysis1998932892909663714
   PubMed Web of Science ®Google Scholar
• MontoroJBAltisentCPicoMCabañasMJVilaMPuigLLRecombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitorHaemophilia1998457627659873885
   PubMed Web of Science ®Google Scholar
• ScaraggiFAde MitrioVMarinoRTreatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injectionsBlood Coagul Fibrinolysis1999101333810070833
   PubMed Web of Science ®Google Scholar
• LorenzoJIMontoroJMAznarJAPostoperative use of rFVIIa by continuous infusion in a haemophilic boyHaemophilia19995213513810215964
   PubMed Web of Science ®Google Scholar
• PeerlinckKVermylenJAcute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitorThromb Haemost19998261775177610613674
   PubMed Web of Science ®Google Scholar
• BaudoFRedaelliRCaimiTMMostardaGSomainiGde CataldoFThe continuous infusion of recombinant activated factor VIIa (rFVIIa) in patients with factor VIII inhibitors activates the coagulation and fibrinolytic systems without clinical complicationsThromb Res2000991212410904100
   PubMed Web of Science ®Google Scholar
• TagarielloGde BiasiEGajoGBRecombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two casesHaemophilia20006558158311012706
   PubMed Web of Science ®Google Scholar
• McPhersonJSutcharitchanPLloydJStreetANelleman JorgensenLYangSIExperience with continuous infusion of recombinant activated factor VII in the Asia-Pacific regionBlood Coagul Fibrinolysis200011suppl 1S31S3410850561
   PubMed Web of Science ®Google Scholar
• FaradjiABonnometFLecocqJKnee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven): a new case report and review of the literatureHaemophilia20017332132611380637
   PubMed Web of Science ®Google Scholar
• NakamuraMTerashimaKTakashimaYAmanoKHorikoshiYMimayaJContinuous infusion of recombinant activated factor VII during and after elbow arthroplasty in a hemophilia A patient with inhibitorsRinsho Ketsueki200243318318811979750
   PubMedGoogle Scholar
• PerezRMartinezRLPiñeroASosaRSequential treatment with bolus and continuous infusion of recombinant factor VIIa for hip arthroplasty in a patient with haemophilia A and inhibitorHaemophilia20028682282512410655
   PubMed Web of Science ®Google Scholar
• TagarielloGRadossiPde BiasiERi SatoRDavoliPGFlexibility of recombinant FVIIa continuous infusion in patients with haemophilia and inhibitorsPoster PO39 presented at: 25th International Congress of the World Federation of Hemophilia2002Seville, Spain
   Google Scholar
• DivanonFHecquardCBorel-DerlonAExperience with use of recombinant activated factor VIIJ Clin Pharm Ther200227213313811975698
   PubMed Web of Science ®Google Scholar
• TagarielloGBissonRRadossiPConcurrent total hip and knee replacements in a patient with haemophilia with inhibitors using recombinant factor VIIa by continuous infusionHaemophilia20039673874014750941
   PubMed Web of Science ®Google Scholar
• HayashiTTanakaIShimaMUnresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitorHaemophilia200410439740015230956
   PubMed Web of Science ®Google Scholar
• SlaouiMLambertTStieltjesNClaeyssensSBorel-DerlonAStudy GroupIntestinal surgery with activated recombinant factor VII prophylaxis in patients with haemophilia A and high responding inhibitors: a report of five casesBlood Coagul Fibrinolysis200415868769115613924
   PubMed Web of Science ®Google Scholar
• MargitSPavelTSmarandaASuccessful major surgery with minimal dosage of rFVIIa in a hemophiliac with high level of alloantibodies to factor VIIIPoster PO54 presented at: 26th International Congress of the World Federation of Hemophilia2004Bangkok, Thailand
   Google Scholar
• HorvathovaDBatorovaAHurtovaZMistrikMSuccessful treatment of hematuria and kidney hematoma with continuous infusion of rFVIIa in hemophilia patient with inhibitorPoster PO28 presented at: 26th International Congress of the World Federation of Hemophilia2004Bangkok, Thailand
   Google Scholar
• SartoriRBissonRBaarsGWOne-stage replacement of infected knee prosthesis in a patient with haemophilia A and high titre of inhibitorsHaemophilia200814237537718179576
   PubMed Web of Science ®Google Scholar
• CandiottoLFulloneFWRicciardiARadossiPTagarielloGCorrection of knee flexion contracture at the time of surgical fixation of a femoral supracondylar fracture in a haemophiliac with inhibitorsBlood Transfus201513233333525369593
   PubMed Web of Science ®Google Scholar
• Mauser-BunschotenEPde Goede-BolderAWielengaJJLeviMPeerlinckKContinuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and BelgiumNeth J Med19985362492559883002
   PubMed Web of Science ®Google Scholar
• TranHTTjønnfjordGEPausAHolmePArFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiencyHaemophilia201117576477021707871
   PubMed Web of Science ®Google Scholar
• MarianiGDolceABatorovaARecombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation – the surgical STERBr J Haematol2011152334034621158750
   PubMed Web of Science ®Google Scholar
• SchulmanSTjønnfjordGEWallenstenRMartinowitzUKenetGContinuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VIIThromb Haemost20059461177118016411390
   PubMed Web of Science ®Google Scholar
• Jiménez-YusteVVillarAMoradoMContinuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiencyHaemophilia20006558859011012708
   PubMed Web of Science ®Google Scholar
• KatoriNYamadaTTakedaJPharmacokinetics of recombinant activated factor VII (rFVIIa) in patients with factor VII deficiencyPoster A1282 presented at: 59th Annual Meeting of the American Society of Anesthesiologists2008Orlando, FL
   Google Scholar
• NagaoAHanabusaHTakedaniHContinuous infusion of rFVIIa during surgery in a FVII-deficient patient: a case report from JapanHaemophilia2014201e110e11224354483
   PubMed Web of Science ®Google Scholar
• RajpurkarMCallaghanMFreyMJSetKChuganiHSoodSManagement of intracranial surgery for refractory epilepsy in severe factor VII deficiency: choosing the optimal dosing regimenHaemophilia2014203e234e23724629109
   PubMed Web of Science ®Google Scholar
• MiyataNIsakaMKojimaHContinuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiencyGen Thorac Cardiovasc Surg201664317718025056454
   PubMed Web of Science ®Google Scholar
• ChristensenAJensenJTNøhrAMCooperDLRoom-temperature-stable recombinant activated coagulation factor VII recombinant: chemical and microbiologic stability over 24 hours during continuous in vitro infusionClin Ther201133121997200122088413
   PubMed Web of Science ®Google Scholar
• BechRMRecombinant factor VIIa in joint and muscle bleeding episodesHaemostasis199626suppl 11351388904188
   PubMedGoogle Scholar
• LusherJIngerslevJRobertsHHednerUClinical experience with recombinant factor VIIaBlood Coagul Fibrinolysis1998921191289622209
   PubMed Web of Science ®Google Scholar
• LusherJMRecombinant factor VIIa (NovoSeven) in the treatment of internal bleeding in patients with factor VIII and IX inhibitorsHaemostasis199626suppl 11241308904186
   PubMedGoogle Scholar
• LusherJMRobertsHRDavignonGA randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study GroupHaemophilia19984679079810028299
   PubMed Web of Science ®Google Scholar
• ParameswaranRShapiroADGillJCKesslerCMHTRS Registry Investigators. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society RegistryHaemophilia200511210010615810910
   PubMed Web of Science ®Google Scholar
• NeufeldEJNégrierCArkhammarPSafety update on the use of recombinant activated factor VII in approved indicationsBlood Rev201529suppl 1S34S4126073367
   PubMed Web of Science ®Google Scholar
• MonroeDMHoffmanMOliverJARobertsHRPlatelet activity of high-dose factor VIIa is independent of tissue factorBr J Haematol19979935425479401063
   PubMed Web of Science ®Google Scholar